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ABSTRACT

Diamidines are a class of compounds that target the minor groove of DNA and have
antiparasitic and antimicrobial properties. Their mechanism of action has not been fully
elucidated, but may include changes in DNA topology. In this study we have investigated such
changes using methods of gel electrophoresis including ligation ladders and cyclization assays.
We found that topology changes were sequence dependent. Compounds typically caused nonanomalously migrating ATATA sequences to migrate as if they were bent, while A5 sequences that
normally migrated anomalously became less so in the presence of certain diamidines. Select
compounds induced changes in cyclization efficiency that were also sequence dependent; DB75
significantly abolished cyclization in A5 containing sequences but enhanced it in sequences
containing ATATA sites.
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Chapter 1: Background and Introduction

1.1 Importance of DNA topology
Due to the importance of DNA local and global shape in multiple biological processes the
ability to abolish bending in highly bent DNA fragments or induce bending in straight DNA is
highly desirable. Many biological processes are mediated by DNA bending. DNA curvature is an
important influence of promoter activity and thus transcription.1 Catabolite activator protein
(CAP), integration host factor (IHF), RNA polymerase and high mobility group proteins (HMG)
are just a few of the many proteins that have been found to induce DNA bending.2, 3
Furthermore, it has been shown that DNA bending is intrinsically important and not just a
consequence of protein binding.4 In some cases, it has been shown that the protein that induces
bends in DNA can be replaced by sequence directed bends, with the bends themselves then
acting as transcriptional activators.5
Proteins, however, are not the only class of molecules that can change the bend of DNA.
A broad array of small molecules has also been shown to change DNA bend. The intrastrand
crosslinker and anticancer drug cis-platin was shown by Rice et al. to bend DNA ~40° towards
the major groove. Mitomycin C (MC), another crosslinker, forms adducts that produce bends of
about 13-16° in DNA.6, 7 In yet another example of the importance of DNA shape on protein
recognition, it is thought that the MC induced curve is a site for DNA bend recognition proteins.
DNA alkylating agents can also generate bending. CC-1065, an antitumor antibiotic, was shown
to bend DNA. Hurley et al. demonstrated that the bending was a consequence of the covalent
bonding reaction of the pyrroloindole subunit containing the cyclic propyl DNA alkylator
group.8, 9

2
While it is not surprising that compounds that bind covalently to DNA or cause single
strand breaks (and thus radically alter its native structure) bend DNA, many minor groove
binders that do not modify the covalent structure have also been shown to bend DNA. The
atomic force microscope (AFM) has been used to show that distamycin can both bend and
straighten DNA, depending on the sequence composition.10 A bent kinetoplast DNA’s mobility
in a polyacrylamide gel was found to increase (presumably because it was straightened) in the
presence of distamycin but increased in the presence of the GC recognizing groove binder
mithramycin.11

1.2 Ligands that bind to DNA
The compounds used in this study that were synthesized by the Boykin group are all
diamidines. These molecules consist of an amidine group at the terminal ends of a chain of
connected, simple aromatic ring systems, such as furans, pyrroles, phenyls, and fused rings such
as benzimidazoles. The most extensively studied diamidine in this group (Figure 1.1) is DB75,
which consists of a central furan ring, flanked on either side by phenyl groups which are then
connected to the terminal amidines. The other diamidines in this study are permutations on this
of this structure. In particular, DB75, DB351, and DB1213 are three analogues differing only in
the central ring’s heteroatom: oxygen (furan), sulfer (thiophene), and selenium (selenophene),
respectively. DB293 and DB940 are also analogous, differing only in the central ring, having
furan and imidazole, respectively, with flanking phenyl and benzimidazole rings. DB244 and
DB60 differ from other members of this set. While their central core is the DB75 prototype, the
amidine is slightly modified; DB244 has a cylcopentyl group replacing the amidine hydrogen on
both sides, while DB60 terminates at either end in an imidazoline.
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Figure 1.1 Structure of compounds used in this research.
As minor groove binders these compounds typically have a crescent shape, which allows
them to fit the contour of the minor groove along the curve of the helix, giving good electrostatic
and van der Waals contact with groove walls and the opportunity for hydrogen bonding.12, 13
However, this does not appear to be a hard and fast rule, as DB 921 has been shown to bind in a
different manner, where only part of the molecule is crescent shaped and the interaction of the
linear portion of the molecule with DNA appears to be mediated by a water molecule.14 Most of
these compounds bind as monomers, however DB293 has been shown to bind to certain
sequences as a dimer.15
The compounds used in this study are minor groove binders and have high affinity for Atract binding sites.12, 14, 16 They also bind to ATAT tracts but usually to a lesser extent, as is the
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case for DB75, DB351, and DB1213. Not all compounds used in this study have had their
binding characterized for the specific sequences used here, but those that are available are
summarized in Table 1.1. Ka values were obtained from hairpins containing the single site
shown under DNA sequence using Surface Plasmon Resonance (SPR).
Table 1.1 Ka for several compounds and their DNA binding sites obtained via SPR. If no
reference is listed, data are unpublished from Dr. W. David Wilson’s lab.

DNA
sequence
A4

ATAT

AATT

A3T3

Compound

Ka (M‐1)

DB75

3.6 x 106

DB351

6.1 x 106

DB1213

1.7 x 107

DB75

2.5 x 106

DB351

4.8 x 106

DB1213

5.6 x 106

H33258

9.0 x 106

Netropsin

1.1 x 108

DB24417

2.2 x 107

DB29315

2.3 x 107

DB92114

2.9 x 108

DB940

8.2 x 106

H3325818

2.4 x 108

Pentamidine

1.3 x 105

Netropsin19

4.0 x 108

DB940

6.5 x 106

H33258

1.8 x 109

Netropsin

6.0 x 108

Several of the diamidine compounds in Figure 1.1 have been shown to be potent
antiparasitics and trypanocides. Trypanosomes are the parasite responsible for Human African
trypanosomiasis (HAT or sleeping sickness). They present a problem that minor groove binders
may be particularly suited to solve. The kinetoplast is an organelle found in the kinetoplastid
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protozoans which contains thousands of networked DNA circles which are responsible for
producing gene products similar to those of mitochondrial DNAs in higher eukaryotes.17 These
circles are rich in AT sequences, the preferential binding site for minor groove binders, making
them an excellent therapeutic target.18 Mathis et al. used fluorescence microscopy to show that
DB75 and other analogues concentrate in the kinetoplast of trypanosomes, which then
subsequently degrade via an as of yet undetermined mechanism.19 Of the compounds in this
series DB75 has the best activity against Trypanosoma brucei brucei, with an IC50 greater than
an order of magnitude than the next best compound, DB244, followed by DB60.

1.3 Commercially available ligands
H33258, netropsin, distamycin A, and pentamidine are commercially available and have
been extensively studied. 20 They were included in this series of compounds for comparison
because they are typical minor groove binders that have also been shown to change DNA
topology, and have antitumor and antimicrobial properties. Pentamidine is one of only two
compounds currently licensed as a treatment for stage 1 of HAT, and has activity against
leishmaniasis.21 In this respect, pentamidine is an especially important standard of comparison
for DB75, since it was hoped that phase III trials involving its pro-drug would prove to have
superior efficacy against HAT and be far less toxic than pentamidine. Since the mechanism by
which pentamidine kills trypanosomes has not been elucidated, we sought to determine if DNA
bending played a role in the compound’s activity against trypanosomes. To this end, ligation
ladder and cyclization assays were harnessed to determine if these commercial compounds were
causing topological changes in the DNA.
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1.4 Polyacrylamide gel electrophoresis
Polyacrylamide gel electrophoresis is a very sensitive method of detecting change DNA
helical topology. 22, 23 As a result, differences in DNA shape from intrinsic sequence directed
helical bending (A-tracts), changes in electrostatics, base modifications, and protein or small
molecule binding to DNA produce detectable changes in DNA mobility on a polyacrylamide
gel.24-26 The effects of various ligands on DNA can be determined qualititatively using single
plasmids alone.11 However, ligation ladders provide far more information on topology changes
than the mobility shift of one band from a single plasmid. Ligation of small oligomers allows the
creation of large fragments of DNA with a specific sequence and known number of equivalent
binding sites. Small changes in topology that might not be visible with a single plasmid with a
binding site at random intervals become measurable when such changes occur at phased binding
sites. Ligation ladder assays provide an opportunity for extensive quantitative analysis of DNA
bending, including estimating the degree of bend from the relative curvature (Cr) which is
defined as the number of A-tracts per helical turn.27 The distance between ideally phased Atracts is designed to alternate between 5 bp and 6 bp. Including the 5 bp length of the A-tract,
this gives an average distance between tracts of 10.5 bp, or the length of one helical turn. The
terms ‘cis’ and ‘trans’ are used to describe whether or not A-tracts are on the same face of the
helix, or on opposite faces of the helix. If A-tracts are in the ‘cis’ configuration then they will
end up ideally phased: their curvature will be additive, and the DNA will be far more bent than if
the DNA has A-tracts in the ‘trans’ configuration, where their intrinsic bends will not be
additive. The relative curvature of a DNA multimer can be determined due to the empirical
relationship described by Crothers and extended by Maher, which shows that the anomalous
mobility of bent A-tract containing fragments is linearly related to the square of the relative
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curvature over a short multimer length of 105 – 189 bp.23, 27-29 While Maher and Crothers used
this method to investigate the effect of sequence composition and phasing on DNA topology,
here it is used to determine the extent of topology change induced by several minor groove
binding compounds. The electrophoresis of small molecule-DNA complexes, however, can be
problematic. The heterocyclic diamidines investigated here are positively charged at the typical
buffer pH of 8.3, which means that they will be migrating in a direction opposite that of the DNA
strands. If their binding constant is sufficiently low, it would be expected that most compounds
would be stripped off of their binding site on the DNA. Surprisingly, some small molecules have
been shown to comigrate with DNA despite the expectation that they would disassociate, and in
spite of the fact that their DNA residency times are far smaller than length of time for
electrophoresis. Several proposals have been made to explain this observation. They include
theories that the gel matrix favors the reassociation process, that it forms a ‘cage’ which
decreases ligand diffusion, or that gel structure increases local concentrations of DNA and ligand
by gel volume exclusion effects. Alternatively, Barcelo et al. proposed that when multiple bands
are migrating in the gel, the fastest band loads the gel with compound such that slower bands will
not disassociate.30 Since ligation ladder analysis deals primarily with fairly small molecular
weight fragments that migrate rapidly, it was hoped that problems with DNA-complex
disassociation could be circumvented by loading a small amount of compound into the gel matrix
itself.

1.5 DNA cyclization assays
Cyclization is another technique that provides information about DNA topology. This
technique has been successfully applied to the study of small molecule and protein mediated
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DNA bending and the influence of sequence composition and phasing on DNA topology.28, 31, 32
The cyclization assay takes advantage of the properties of DNA circle formation, which depend
upon proximity of the intermolecular ends.31 Thus, a DNA oligomer whose bends are phased (as
in the cis oligomer) will have ends that are on average closer to one another and more likely to
be covalently closed by T4 ligase (cyclize) than DNA with unphased bends (as in the trans
oligomer) or a DNA sequence that lacks A-tracts. Cyclization assays are complementary to
mobility shift assays in that they provide information on DNA topology similar to that provided
by shift assays. Each method has its own advantages. The DNA-small molecule interactions in
a cyclization assay occur in solution, and gel electrophoresis is only used to separate and
subsequently calculate the relative intensities of the products of ligation. The effects of multiple
compounds on cyclization can be compared directly on the same gel. In the mobility shift assays
DNA-ligand interactions occur in the matrix of the polyacrylamide gel, with unknown effects of
the gel on DNA-ligand interactions. Furthermore, as noted earlier, for complete quantitative
analysis it is necessary to put compound in the gel to ensure that the small molecule does not
disassociate from the DNA as gel electrophoresis proceeds. This requires the presence of
compound in each gel. Not only does this require significant amounts of compound, it means
that each compound requires a separate gel. The advantage of the shift assay over the cyclization
assay is that the enzyme performs its function in the absence of compound, since ligation is
terminated before the compound is introduced into the system. Thus any direct inhibition of the
enzyme by compound is null.
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1.6 Goals
This thesis seeks to answer the following questions: do minor groove binding diamidines,
specifically DB75, cause large changes in DNA topology? If so, can such changes be correlated
with activity against HAT? In pursuit of the answer to the above questions, the usefulness of the
ligation ladder and cyclization assays as tools for determining DNA topology changes has also
been investigated.

10
Chapter 2: Materials and Methods

2.1 DNA binding ligands
All compounds not commercially available were prepared and provided by Professor
David Boykin and coworkers at Georgia State University. Their syntheses have been previously
described.33-37 Netropsin, distamycin A, and pentamidine were purchased from Sigma-Aldrich
(St. Louis, MO), and H33258 was purchased from Calbiochem (La Jolla, CA). Compounds were
typically prepared as 1 mM stock solutions in water, by weighing out an appropriate amount of
compound using an analytical scale, and adding double distilled water. Stock solutions of
netropsin were kept frozen at -4 °C, all others were kept refrigerated at 4 °C.

2.2 DNA oligomers
For this study, two duplexes already investigated by Maher et al. 28 (1 and 2) and three
new duplexes were used (3-5) as shown in Figure 3.1. An additional oligomer was designed as a
molecular marker (M2) whose sequence is shown in Figure 2.1. All have cohesive ends
consisting of a two bp (CC) overhang on the 3’ end of one strand and two bp overhang (GG) on
the 3’ end of the complementary strand. This allows them to be efficiently ligated. Lypholized
DNA oligomers were purchased from Integrated DNA Technologies, Inc. (Coraville, IA) with
HPLC purification. Lyophilized DNA vials were centrifuged to ensure all solids were at the
bottom of the vial and enough water was added to bring the concentration to approximately 1.0
mM, based on the reported amount of DNA from IDT. The concentration of these single
stranded DNA samples was then determined using a Cary 300 UV-visible spectrophotometer
(Varian, Walnut Creek, CA) at A260 and the extinction coefficient provided by the manufacturer.
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These stock solutions were stored at -4 °C. Complementary strands (100 µM) were then
combined in a 1:1 ratio (based on their calculated concentration) and annealed in NEB 1X
ligation buffer (New England BioLabs, Ipswich, MA) containing 50 mM Tris-HCl, 10 mM
MgCl2, 10 mM dithiothreitol, 1 mM ATP, and 25 µg/mL bovine serum albumin. These working
solutions were stored at 4 °C.

2.3 Ligation ladders
Oligomers were ligated using a procedure similar to that previously described.18, 28, 29
Annealed oligos (6 µM) were incubated for 30 min at 37 °C in a reaction mixture (100 µL)
containing 40 U of T4 polynucleotide kinase (New England Biolabs) in 1X ligation buffer.
These kinased oligomers (2 µM) were then assembled into ligation reactions (200 µL) with 1200
U of T4 DNA ligase (New England BioLabs) in 1X ligation buffer (50 mM Tris-HCl, 10 mM
MgCl2, 10 mM dithiothreitol, 1 mM ATP, and 25 µg/mL bovine serum albumin). Room
temperature ligation time was 30 min followed by an inactivation time of 20 min at 65 °C. T4
DNA ligase is not an efficient ligator of ssDNA.38 Thus, ssDNA leftover after annealing is of
little importance, and will likely run off the gel. An aliquot of the ligated oligomers was then
digested with Bal-31 nuclease in order to distinguish circular multimers from the linear ones.
DNA oligos (~1 µM) were assembled into reactions (102 µL) containing 2U of Bal-31 (New
England BioLabs) in 1X Bal-31 buffer (20 mM Tris-HCl, 600 mM NaCl, 12 mM CaCl2,
12 mM MgCl2, 1 mM EDTA) and were incubated at 30 °C for one hour.
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2.4 DNA cyclization assay
Cyclization assays were prepared as described above for ligation ladders using the same
oligomers, except that DNA (2 µM) was incubated (10 min) with various concentrations of
compound prior to ligation and during ligation (30 min). Samples were digested with Bal-31 (see
above) to give only the circular products, which were then separated by gel electrophoresis as
described below.

2.5 PAGE
Ligation ladder products were separated on 8% native polyacrylamide gels (1.5 mm
thick, 20 cm long) prepared from a 40% acrylamide solution (19:1, bis-acrylamide:acrylamide,
Bio-Rad, Hercules, CA or 29:1, EMD, Gibbstown, NJ). The 10X TBE running buffer was
prepared by combining the following into a 2 L beaker containing 1.6 L ddH2O;
216 g tris(hydroxymethyl)aminomethane (Tris, Mallinckrodt Baker, Phillipsburg, NJ),
110 g boric acid (Sigma, St. Louis, MO),
14.9 g disodium ethylenediamine tetraacetate acid (EDTA, Fisher, Fair Lawn, NJ)
Once all solids were dissolved, pH was adjusted to 8.3 using sodium hydroxide pellets
(Aldrich Chemical Co., Milwaukie, WI). Gels were made by combining the following into a 50
mL disposable plastic tube:
10 mL 40 % acrylamide solution
5 mL 10X TBE
34.5 mL double distilled water
50 µL N,N,N',N'-tetramethyl-ethane-1,2-diamine (TEMED, Bio-Rad)
5 µL 1mM compound (typical volume)
0.5 mL ammonium persulfate (0.1 g/mL) in water (Fisher Scientific)
After shaking, this mixture was poured into the glass plate gel casting assembly. After
the gel polymerized, the comb was removed and the wells were rinsed to remove any polymer
debris. Gels were primed with a 30-60 min, 25 °C, 200V pre-run prior to sample loading in
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order to stabilize amperage (typically starting amperage was ~55 mA), equilibrate the gel to the
appropriate temperature, and remove any excess ammonium persulfate. An appropriate amount
of 6X Load Dye (Promega, Madison, WI) was added to the samples and they were loaded into
separate wells of the gel.
Samples were electrophoresed at 200 V (10 V/cm) and 25 °C for 225 min in a BioRad
Protean IIxi gel apparatus in 1X TBE buffer (0.089 M Tris, 0.089 M boric acid, 2.0 mM EDTA,
pH 8.3) using a Bio-Rad PowerPac Basic 300 power supply. Gel apparati were connected to
circulating temperature control systems, which kept the gels at the desired temperature
throughout the experiment. For experiments at temperatures significantly different from room
temperature, the apparatus was insulated and a digital thermocouple was taped to the glass plate,
which was monitored to ensure proper temperature. Samples of 1µM ligation ladder (in units of
21 bp oligomer, typically 10 µL) and an appropriate molecular marker were incubated with test
compounds at a concentration giving a ratio of 1:1 compound to DNA AT binding sites, unless
otherwise noted. The 1X TBE running buffer in the lower buffer chamber and the gel itself also
contained the same compound as the one present in the ladder samples.
The appropriate amount of compound to use in the gel was calculated in the following
manner using the simple equation for the binding of an isolated DNA site and a ligand which can
be represented as follows:
DNA + Ligand Æ Complex
This can be rearranged to be set equal to the binding constant.
K = [Complex]/[Ligand][DNA]
Using DB75 in this example, the DNA concentration [DNA] was 2 µM, since the typical
concentration of 21 bp oligomer that goes into each well is 1µM and each mole of 21 bp

14
oligomer has two moles of binding sites for compounds that bind AT tracts. For most gel
electrophoresis experiments [Ligand] in the gel is 0.1 µM. The value for Ka for DB 75 is salt
dependent, and therefore the binding constant for DB75 is higher than that listed in Table 1.1.
The Ka values in Table 1.1 are from high salt conditions typically used in SPR (MES10, 100 mM
NaCl ), whereas gel electrophoresis is performed under relatively low salt conditions. Under low
salt DB75 has a binding constant of about 2 x 107M-1. Inserting these values into their
appropriate places gives;
DNA
+
DB75 Æ Complex
x
(2 x 10-6M – x) (0.1 x 10-6M)
K = [Complex]/[DNA][DB75]
2 x 107M-1 = x/(2 x 10-6M – x)(0.1 x 10-6M)
Solving for x gives [Complex] = 1.33 x 10-6 M. This means about 70% of the total DNA is
bound. However, due to the ‘cage effect’ of the gel, as noted earlier, 70% is really the lower
limit and the expected total of DNA bound is probably much higher. Thus, if the desired
concentration in the gel was at least equal to the concentration of free DNA in the sample, the
final compound concentration in gel and buffer would be about 0.6 µM. Typically, gels
contained 0.1 µM – 0.3 µM compound and buffer contained at least 0.1 µM of compound.
Ligand concentration in the buffer was often at the lower concentration in an attempt to conserve
compound, since typical running buffer volumes (bottom chamber only) were 900 mL per gel
experiment. Concentrations were also minimized because higher concentrations of compound in
the gel often gave large background fluorescence.
Experiments staged to determine if marker mobility was susceptible to the ligands present
in the gel were performed simultaneously on opposite sides of the same gel box, with one gel
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containing DB75 and one without. Gels were run simultaneously on the same box, to minimize
variation. Setup was as already described, save for the absence of compound in the buffer.
Gels for the cyclization assays were 8% native polyacrylamide gels prepared from 40%
acrylamide solution (29:1, bisacrylamide:acrylamide) (EMD, Gibbstown, NJ). Typical running
conditions were 200 V for 360 min at 25 °C.
In lieu of radiolabeling, gels were stained with SYBR® Gold Nucleic Acid Gel Stain
(Molecular Probes, Eugene, OR) at the concentration recommended by the manufacturer for 1
hour. Stained gels were imaged using a UVP BioImaging Systems Epi Chem II Darkroom
(UVP, Upland, CA) equipped with a SYBR® Gold filter.

2.6 Molecular weight markers
The following molecular weight markers were used to assign base pair values to the
ligation ladder samples: 20 bp ladder (M1)(Bayou Biolabs, Harahan, LA), 100 bp ladder
(Promega) and Hi-Lo ladder (Bionexus, Inc.). The sequence is known for some of the
commercial markers used in the study. Bayou Biolabs indicated that the 20 bp marker was
spiked with a 100 bp fragment for which the sequence was not known but was a ligation ladder
of the oligomer in Figure 2.1. The manufacturer assumes a 20 bp total molecular weight; even
though the starting oligomer is actually a 16 bp fragment with 4 bp cohesive overhangs. In
addition to the commercially available ladder standards, a single-stranded DNA (ssDNA) (IDT)
was used as a standard to determine if the marker mobility was compromised by the presence of
different compounds. Since the ssDNA sequence is self complementary, two bands can be seen
on a stained gel; one for the single stranded hairpin and one for the duplex. In order to further
investigate the effect of compound in the gel on marker mobility, an oligomer was designed that
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had the same composition as oligomers 1-5, but lacked a preferred binding site for the
compounds in Figure 1.1. It contained the same cohesive ends as the other oligomers and was
ligated in the manner already described. This oligomer (Figure 2.1) is referred to as M2.

Figure 2.1 Sequences of markers. M1 and M2 were used to assign molecular weight to
ligation ladders.

2.7 Data fitting and analysis of ligation ladders
Scanned gel results for migration analysis and molecular weight assignment for ligation
ladder products, separated as described, were obtained using ImageQuant TL (Amersham
Biosciences, Piscataway, NJ). The relative mobility (RL) for each multimer was calculated,
where RL = Lapparent/Lactual, and plotted as a function of Lactual. Lactual is determined by adding 21
bp to each sequential band, starting with the bottom most bands while skipping bands that are
due to circular ligation products. For most gels, the unligated, 21 bp, starting material was not
visible (as it had migrated off the gel) and the lowest band visible is the first ligation product (42
bp). However, in cases where it did not migrate off, it was easy to determine the identity of the
first band relative to the 20 bp molecular weight marker since the migration of the 21 bp
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oligomer was not significantly anomalous. While technically the initial band was 19 bp, the two
base overhangs on either side were treated as an additional 2 bp for the purpose of molecular
weight assignments. This assumption has been used by both Maher and Crothers,27-29 and is
especially negligible at higher molecular weights. For example, a multimer consisting of three
oligomer units could either be assigned a molecular weight of 63 bp, including overhangs as an
additional 2 bp, or 61 bp, excluding the overhangs. This is a difference of 2 bp, or 3% of the
total assigned bp size. With larger oligomers, the difference is less than the experimental error in
determination of mobility.
RL values for multimers 105 bp through 189 bp were averaged from three gel
experiments for the cis A5 duplex containing no compound. Data were fitted to the following
equation as described by Crothers27 and extended by Maher29,
RL-1 = (aL2-b)Cr2

[1]

where L is the length of the multimer and Cr is the relative curvature, or the number of
phased A tracts per helical turn. For the cis A5 duplex, duplex 1, Cr = 1. Crothers reported
values of a = 9.6 x 10-5 and b = 0.47, but these values vary with electrophoretic conditions such
as temperature, gel percentage and acrylamide:bisacrylamide ratios. Values were obtained for a
and b using nonlinear least squares fitting in KaleidaGraph (Synergy Software, Reading, PA).
These values were then substituted back into Equation 1 and Cr values were obtained by fitting
the data for duplexes 2-4 without compound, and duplexes 1-4 in the presence of various minor
groove binders.
Cr values for DNA in gels at temperatures other than 25 °C were calculated in two
different ways. First they were calculated relative to cis A5 at 25 °C, in order to determine the
effect of temperature on curvature. This made it possible to determine whether the curvature of
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each oligomer increased or decreased at different temperatures, relative to cis A5 at 25 °C which
has a Cr value of 1.00. Secondly they were calculated as a function of cis A5 at 35 °C and 15 °C
(each of them assigned the value of 1.00) in order to determine if the direction and the magnitude
of change in the presence of compound was temperature dependent.

2.8 Reproducibility and error
In order to determine the reliability of this method and calculate the experimental error in
any curvature assignments, three gels with DB75 and three without compound were run. Two
gels experiments were performed on one apparatus and one on another, however, both apparati
were Bio-Rad Protean IIs. Two gels were run on the same day and compared to a gel run two
months prior to ensure reproducibility. The average and standard deviation of RL from these
three gels without compound, and in the presence of DB75, were calculated for each band of the
four oligomers and plotted vs L. Using this method, the average and standard deviation for each
point were calculated from three values, except in some cases where bands could not be assigned
from one gel, then the average and standard deviation were from at least two values. These
average RL values were then transformed into plots of average RL-1 as a function of L2 for 105
bp – 189 bp as described above. The weighted fits and the estimated fitting error were
determined for these plots for each oligomer in the presence or absence of DB75. Fitting errors
were typically less than 0.01 (in units of relative curvature). To determine an estimate of the
error in calculated Cr values, data from multiple gels was averaged and the standard deviation
was calculated. Data for trans A5 and trans ATATA oligomers in the presence of DB75 were
from two gels.
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2.9 Cyclization assay analysis
Cyclization assay analysis of cis A5 in the presence of various compounds was performed
in a manner similar to that described previously by Maher.28 ImageQuant TL software was used
to assign the intensity (I) of each band as a percentage of intensity for all circular products. This
value was divided by the number of ligated duplexes (n) present in the circle to yield Dnorm.
Dnorm = I/n

[2]

Cyclization efficiency (E) was then found by dividing Dnorm for each circle (i) by Dmax, the value
corresponding to the circle with the largest Dnorm.
E = Dnorm,i/Dnorm,max

[3]

E was then plotted against the size of each circle in bp, where bp assignments were based on
Maher’s results for cis A5. The L value (Lmax) at which E is maximum was found to be related to
Cr from ligation ladder assays by the following equation;
Lmax = 288.64e-0.674Cr

[4]
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Chapter 3: Results and Discussion

3.1 Ligation ladders
In the absence of minor groove binders oligos exhibited differences in mobility that are
greater than experimental error at 63 bp, or three multimers (Figure 3.1). The results are in
agreement with those of Maher28, 29 and Crothers27 which showed that cis A5 tracts migrate
anomalously relative to A-tracts that are not ideally phased. Of the four oligomers tested, cis A5
tracts migrated the most anomalous, followed by trans A5 and cis ATATA. The trans ATATA
oligomer migrated essentially as a random sequence DNA does, meaning that its actual and
apparent length are almost equal (RL ≈ 1).

Figure 3.1 Duplexes used in this study (A). A typical gel from a ligation ladder experiment
showing duplexes 1-5 and a 20 bp marker (M1). Black arrows point to 21 bp
ligated linear multimers. The first arrow, L2, points to the 42 bp band that is the
first ligation product. Blue arrows indicate the circular products in the cis A5
duplex (1)(B). Duplex 5 is not shown in this gel.
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Such differences in mobility are visually striking and are especially interesting when one
considers that the sequence composition of all four oligomers is exactly the same, and that they
differ only in their sequence order. The results with cis and trans A5 are in agreement with the
literature and reemphasize the uniqueness of A-tracts, which are the source of the decrease in
mobility because they introduce a bend in the double helix axis. Cis A5 (oligomer 1 in Figure
3.1), being the more intrinsically bent DNA, migrates the slowest but also produces circular
products at much lower molecular weights (or fewer multimer units) than the other oligomers.
This is expected due to the proximity of the intermolecular ends, brought about by the phased
bends. Cis AAATT (shown in Figure 3.2, lane 5) migrated slower than cis ATATA, but faster
than cis A5. The cis ATATA (3) band migrates similar to M2, which is of the same composition
as the other oligomers but lacks A-tracts. Figure 3.2 also shows that M1 and M2 migrate
differently due to the difference in their molecular weight; the bright band in M1 is a 100 bp
band, the corresponding band in M2 is 105 bp. They also differ in their number of overhanging
bases. M2 is the better marker for assays that include compound in the gel, since it more closely
resembles the oligomers of interest in terms of sequence, has the same number overhangs, and
lacks a binding site recognized by the compounds of interest used in this experiment.

3.2 Calculation of relative curvature
Plots of RL vs Lact for ladders both with and without compound made it possible to
visualize mobility changes in the ligation ladders due to the presence of compound. Sample
plots are shown below for DB75 (Figure 3.3) and DB921 (Figure 3.4).
Differences in apparent mobility induced by compound are immediately obvious in
Figure 3.3 and 3.4. DB75 increased the apparent mobility of cis A5 and trans A5 while causing
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an even larger and opposite change in the mobility of both ATATA oligomers. DB921 also
caused sequence dependent mobility changes; both relatively unbent ATATA oligomers
migrated as if they were bent, while cis A5 and trans A5 remain relatively unchanged.

Figure 3.2 8% PAGE (29:1) gel from a ligation ladder experiment showing the ligation
ladders of duplexes 1, 3, and 5 (the three cis oligomers). A 20 bp marker (M1)
and the shuffled marker (M2) are also shown. No compound was present in
either the buffer or the gel. Colored arrows point to the corresponding 105 bp
band of each sequence, the black arrow points to the 105 bp band of M2, the
100 bp band of M1 is double intensity (no arrow).
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Figure 3.3 Relative length (RL) plotted as a function of actual length (Lact) for cis A5 (red
triangles), trans A5 (purple circles), cis ATATA (green triangles), and trans
ATATA (purple circles) without compound (left) and with DB75 (right). Arrows
indicate the DNA ligate with Lact of 168 bp for cis ATATA (green) and cis A5
(red).
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Figure 3.4 Relative length (RL) plotted as a function of actual length (Lact) for cis A5 (solid
red triangles), trans A5 (solid purple circles), cis ATATA (solid green triangles),
and trans ATATA (solid blue circles) with DB 921 and cis A5 (open red
triangles), trans A5 (open purple circles), cis ATATA (open green triangles), and
trans ATATA (open blue circles) without compound.
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In order to obtain quantifiable information about relative curvature, data from RL vs Lact
plots were transformed into plots of RL-1 vs Lact2 (Figure 3.5). The plot for ligation ladders with
no compound is shown below. Values for a and b were found from the linear fit of the curve for
cis A5, assuming a Cr value of 1.0.
Using the equation found from cis A5, the relative curvature for trans A5 was found and
although they are not A5 tracts, the curvature for cis ATATA and trans ATATA relative to an A5
tract was determined as well. By definition, the Cr value for cis A5 is 1.0, while the trans A5 was
0.59. As expected, the Cr values for cis ATATA and trans ATATA were significantly less than
cis A5, since AT tracts have less intrinsic curvature. Their Cr values were 0.33 and 0.25,
respectively.
Values for a and b differed significantly for 29:1 gels and 19:1 gels. For 19:1 gels a =
1.514 x 10 -5 and b = 0.017 whereas for 29:1 the values were a = 3.454 x 10 -5 and b = 0.077.
Relative curvature values did not differ greatly however, cis A5 was (by definition) 1.0, trans A5
was 0.59, cis ATATA 0.30, and trans ATATA 0.20. The data are not an average and are from
one gel. Because the values were found to be so similar, it is assumed that Cr values obtained in
polyacrylamide gels with one concentration of crosslinker can be compared to data from gels
with a different concentration of crosslinker. Figures 3.6 and 3.7 show two gels run for the same
amount of time and under the same conditions that differ only in the amount of bisacrylamide in
them. The 29:1 acrylamide is superior to 19:1 when making gels for this assay since better band
resolution over a broader molecular weight range is obtained.
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Figure 3.5 RL-1 vs Lact2 for the standard gel (average of three runs) in the absence of
compound. Cr was found for cis A5 (red triangles), trans A5 (purple circles), cis
ATATA (green triangles), and trans ATATA (blue circles) with no compound
present.
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Figure 3.6 Ligation ladders with no compound on a 29:1 gel (A) and 19:1 gel (B). The
distance that DNA travelled was dependent upon the acrylamide to bis ratio,
with lower amounts of bis yielding more rapid migration. M1 denotes the 20 bp
marker, 1-4 indicates the oligomer in that lane, and Bal-31± indicates whether
or not the sample was digested prior to electrophoresis.
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Figure 3.7 RL as a function of Lact for ligation ladders in the presence of 0.1 µM DB75 on an
8% PAGE 29:1 gel (A/B) and 19:1 gel (C/D) for cis A5 (red triangles), trans A5
(purple circles), cis ATATA (green triangles), and trans ATATA (blue circles).
Arrows indicate a 100 bp band. M1 corresponds to the 20 bp commercial
marker.

While the plots of RL vs Lact (Figure 3.7 A and C) look somewhat different, the Cr values
obtained from them are within experimental error of one another.
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Once the fit for the four oligomers in the absence of compound was obtained these values
were used as a standard from which the effects of various compounds were measured. Multiple
compounds were investigated and a typical plot (DB75) is shown in Figure 3.8.
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Figure 3.8 Actual length squared (Lact2) plotted as a function of relative length minus one
(RL-1) in the presence of DB75 for cis A5 (red triangles), trans A5 (purple
circles), cis ATATA (green triangles), and trans ATATA (blue circles).
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For each oligomer, a plot was made with the standard (no compound) curve and curves in
the presence of various compounds (Figures 3.9-3.12). They were fit to the following equation
that described the average cis A5 ligate and were then solved for Cr,
RL-1 = (0.017 + 1.514 x 10-5Lact2)(Cr)2

[5]

Thus, values for Cr that are greater than 1.0 are more bent than the cis A5 oligomer and values of
less than one represent oligomers that are less bent than the cis A5 oligo.
The fits for most data were good; however, fits for compounds that have almost zero or
negative slope, such as H33258 with cis ATATA, and DB940 with trans ATATA for example,
are problematic and cannot be described properly by a Cr value using a strict Maher and Crothers
approach. It was found that at very low values of Cr (DNA that is fairly linear), the influence of
the intercept was such that accurate fits for the data were not always possible. Allowing the
intercept to ‘float’ i.e. by only fixing the value for a in Equation 1 but not b, and letting
Kaleidagraph find the intercept, the fits for the problematic data were much improved. However,
since the Cr values for compounds that induced a large change were of more interest, and it was
less important to have strict Cr values for compounds that didn’t induce a change, the strict
approach was taken. Maher and Crothers did not examine sequences with very low values for Cr
and thus probably did not encounter this problem. In addition, some plots are missing a data
point, since circles were not analyzed and sometimes obscured data points for linear oligomers.
These plots (Figure 3.9 - 3.12) are shown for each of the four oligomers in the presence of
various compounds.
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Figure 3.10 Fitting of RL-1 vs Lact2 to obtain Cr values for cis ATATA ligation ladders in the
presence and absence of various compounds.
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Figure 3.11 Fitting of RL-1 vs Lact2 to obtain Cr values for trans A5 ligation ladders in the
presence and absence of various compounds.
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Figure 3.12 Fitting of RL-1 vs Lact2 to obtain Cr values for trans ATATA ligation ladders in
the presence and absence of various compounds.
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Table 3.1 summarizes the Cr values for all four oligomers in the presence and absence of
various compounds. A wide variety of effects were observed for compounds, with many
compounds causing a decrease in bend in one sequence and an increase in the other. For the
ligated cis A5 oligomer Cr was changed by an amount larger than experimental error for most
compounds except DB940, DB921, distamycin, pentamidine, H33258, and Netropsin. DB60,
DB75, and DB244 decreased Cr to about 0.8 from 1.0, while DB293, DB351, and DB1213 all
significantly increased Cr by at least 0.1. Overall, the greatest change in the Cr of cis A5 was
induced by DB75 and DB244, which both cause curved DNA to migrate as if it was more linear,
and DB293 which had the opposite effect, causing curved DNA to migrate even more
anomalously. The Cr values for trans A5 were harder to quantify due to problems with fitting
lines that had little to no slope to the equation. Allowing the intercept to vary or ‘float’ improves
the fit, as explained previously, but that option was not explored here. A re-fitting of the data
may provide more accurate Cr values, however, it can be seen visually that there is not much
change induced (Figure 3.11). Overall, changes in trans A5 were not large, which is expected
since de-phasing the A-tracts makes changes in curve much harder to detect. Not surprisingly,
most compounds did not show a significant change in trans A5, with the exception of DB293 and
DB1213, which increased Cr and DB75 and DB244 which decreased it. These compounds also
showed the greatest change in the cis A5 Cr. For the cis ATATA oligomer, almost all
compounds increased Cr, except distamycin and H33258. Netropsin, DB921, and DB244 caused
the largest increases. It is not clear whether these increases are due to intercalation. However,
this possibility seems unlikely, since a search of the literature found no evidence for intercalation
as the primary mode of binding for the three most extensively studied compounds: Netropsin,
H33258, and distamycin. None of the compounds studied appeared to decrease the Cr in either
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of the ATATA oligomers, but this is understandable considering this sequence has very little
intrinsic curvature. Analysis of trans ATATA suffers from the same problem as trans A5; the
sequence is very linear so it is hard to calculate a value for Cr. Results for trans ATATA for
DB940 were very unusual (Figure 3.12) because curvature appeared to decrease with increasing
length. The results for trans ATATA for other compounds mirror those of cis ATATA, with the
greatest changes in Cr occurring with DB1213, DB921, and netropsin.
Overall, the most striking change in DNA topology occurred in the cis ATATA sequence.
As noted before, this sequence is expected to be fairly uncurved, which is supported by the
ligation ladder data in the absence of compound. However, upon addition of many compounds,
DB921 in particular, a large change in mobility is seen, suggesting that the rather linear DNA is
bending, or perhaps the compound is intercalating between the bp and unwinding and
lengthening the DNA. Again this seems highly unlikely, since these compounds are much more
likely to favor binding in the minor groove rather than between bases, especially at the fairly low
concentrations used in these experiments. Furthermore, the difference in cis ATATA and trans
ATATA sequences suggests that the observed results are not due to intercalation but rather are
due to topology. If intercalation were the probable cause of such changes in mobility, it is
unlikely that the assay would be able to differentiate a difference in mobility between cis and
trans oligomers.
DB921 and several other compounds changed the Cr value of the ATATA sequence from
0.3 to 1.0, in the same range as the value for the phased A-tract (cis A5). Only distamycin and
H33258 failed to increase the Cr value of ATATA sequences. The lack of significant change in
distamycin Cr values over a range of ratios suggests that having compound in the gel ‘covers up’
changes in migration that would otherwise be present by filling binding sites that are unoccupied
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during incubation. All other compounds investigated change the value by a large amount, even
doubling or tripling the curvature in some cases. This is interesting, since these two compounds
are the only compounds that lack a charge at both ends of the molecule. However, it seems
unlikely that charge effects are the single explanation for the observed difference in mobility, for
the same reason that intercalation explains the large change in the mobility of ATATA
sequences. Again, if the difference were the results of charge then no difference between cis and
trans should be detectable, and it clearly is. Figure 3.13 displays select information from Table
3.1 as a histogram for ease of comparison.

Table 3.1 Cr values for four oligomers in 19:1 gels at 25 °C. All ratios are expressed as
compound to binding site.
cis A5

trans A5

cis ATATA

trans ATATA

No compound average

1.00

0.55

0.31

0.25

DB60

0.82

0.50

0.47

0.24

DB75

0.80

0.39

0.78

0.32

DB244

0.80

0.36

0.99

0.41

DB293

1.19

0.70

0.75

0.44

DB351

1.14

0.59

0.70

0.40

DB921

1.03

0.45

1.02

0.50

DB940

0.96

0.54

0.42

0.32

DB1213

1.15

0.62

0.94

0.59

Distamycin A 0.5:1

0.99

0.55

0.29

0.16

Distamycin A 1:1

0.92

0.54

0.29

0.25

Distamycin A 2:1

0.93

0.53

0.33

0.32

Pentamidine

0.99

0.52

0.77

0.41

H33258

0.93

0.56

0.32

0.21

Netropsin

0.93

0.50

1.01

0.57
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Figure 3.13 Histogram showing Cr for select compounds with cis A5 (blue) and cis ATATA
(green). Compounds are placed in order of least to greatest change in cis
ATATA, relative to the value for no compound (far left).

3.3 Temperature dependence of Cr
Tables 3.3 – 3.6 summarize Cr values at differing temperatures, while Table 3.2 contains
Cr values with a different amount of bis-acrylamide crosslinker. A comparison of the values in
Table 3.2 with those in Table 3.1 again reiterates the independence of Cr from the amount of
crosslinker in the gel, allowing the comparison of data from gels that differed in bis-acrylamide
concentration.

Table 3.2 Cr values for four oligomers in 29:1 gels at 25 °C.

No compound
DB75

cis A5

trans A5

cis ATATA

trans ATATA

1.00
0.81

0.59
0.44

0.31
0.78

0.20
0.35
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Another interesting result was that while the Cr values for the oligomers without
compound changed with temperature, those for DB75 did not depend as much on temperature.
A comparison of Table 3.3 and Table 3.4 shows that differences in Cr values amongst the four
oligomers in the absence of compound do not change for a given temperature.

Table 3.3 Cr values for four oligomers in 19:1 gels at 35 °C, fit to cis A5 at 35 °C.

No compound
DB75

cis A5

trans A5

cis ATATA

trans ATATA

1.00
0.89

0.60
0.49

0.33
0.91

0.25
0.41

Table 3.4 Cr values for four oligomers in 19:1 gels at 15 °C, fit to cis A5 at 15 °C.

No compound
DB75

cis A5

trans A5

cis ATATA

trans ATATA

1.00
0.74

0.59
0.38

0.32
0.65

0.24
0.29

In other words, if all sequences are normalized to cis A5 (Cr = 1.0) at one particular
temperature, then trans A5 is about 0.6 relative to cis A5 whether the temperature is 15 °C or
35 °C. However, if Cr values are relative to cis A5 at 25 °C, differences become apparent for the
sequences without compound. It was expected that the Cr values would change for oligomers in
the absence of compound, since it has been shown previously that bends in DNA relax with
increased temperature, and are enhanced at lower temperatures39. This expected result is
consistent with experimental Cr values for cis A5 in the absence of compound decreasing at
35 °C (Table 3.5) and increasing at 15 °C (Table 3.6).
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Table 3.5 Cr values for four oligomers in 19:1 gels at 35 °C, fit to cis A5 at 25 °C.
cis A5

trans A5

cis ATATA

trans ATATA

No compound

0.89

0.53

0.30

0.22

DB75

0.79

0.44

0.81

0.36

Table 3.6 Cr values for four oligomers in 19:1 gels at 15 °C, fit to cis A5 at 25 °C.

No compound
DB75

cis A5

trans A5

cis ATATA

trans ATATA

1.09
0.81

0.64
0.42

0.35
0.71

0.26
0.32

This trend also holds true for the trans A5 sequence, although the changes are very small.
Both cis and trans ATATA in the absence of compound change very little over this temperature
range. This is probably due either to their intrinsic linearity or the difficulty in assigning
accurate Cr values to them. Cr values for DB75 are far more static. For example, while the ‘no
compound’ values for cis A5 change by about 0.2 units from the lowest value of 0.89 at 35 °C to
the highest value of 1.09 at 15 °C. Over this temperature range cis A5 in the presence of DB75
varies by only 0.02 units, a difference that is within experimental error. The values for cis and
trans ATATA in the presence of DB75 also differed very little from one another over the same
temperature range. If, however, as stated earlier, they did not differ much in the absence of
compound either. Thus, while the Cr values for cis and trans A5 oligomers with no compound
were temperature dependent, the values for them in the presence of DB75 changed very little and
are very close to one another at 15 °C, 25 °C, and 35 °C. Also, the large change in Cr induced by
DB75 in both the cis and trans ATATA oligomer remained over the same temperature range.
This can be seen visually as well in the RL vs Lact plots of this data (Figure 3.14 and 3.15).
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Figure 3.14 Plots of RL vs Lact for four DNAs at 15 °C, 25 °C, and 35 °C show the
dependence of DNA topology on temperature, in the absence of DB75.
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Figure 3.15 Plots of RL vs Lact for four DNAs at 15°C, 25°C, and 35°C show the dependence
of DNA topology on temperature, in the presence of DB75.
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3.4 Calculation of error in Cr values
Since the minor groove binding compounds in this study caused relatively small changes
in mobility and thus relative curvature (as compared to large deflections greater than 10°
reported for some DNA crosslinkers and even larger bends induced by proteins), it was
necessary to determine if a difference in Cr of 0.1 was significant. Figures 3.16 and 3.17 show
that results from gels that contained compound and those that did not were reproducible. There
was greater error in the cis oligomer than the other three oligomers, with the error being very
small in the two trans oligomers. The error increases in the cis and trans oligomers with
increasing size and the error bar for the point at 231 bp is large for cis. The increase in error in
data at higher molecular weight is due to the lack of molecular weight `standard 20 bp bands
above 380 – 400 bp or bands that are present but too faint to be measured. If the molecular
weight of the sample was slightly above the largest standard band, then relative migration values
were used to estimate that band’s molecular weight. The 189 bp band for the cis oligomer
typically migrates at 380 – 400 bp. Thus, above 189 bp, the cis A5 oligomer is extrapolated from
the cubic spline curve, giving large error. Fortunately, the oligomers we are interested in are 105
bp to 189 bp and the error in this range is acceptable. The error in Cr was obtained from the
curve fitting RL-1 vs Lact2 for each oligomer in the presence and absence of DB75 (Figure 3.18).
Cr values were fairly reproducible, as is shown in Table 3.7. Standard deviations for
these values were low, with the highest being 0.03 for the cis A5 oligomer in the absence of
DB75 and the lowest 0.01. The higher error associated with cis A5 without DB75 is consistent
with the observation that greater variation occurs in lower mobility bands, due to the absence of
higher molecular weight bands in the 20 bp marker.
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Figure 3.16 Average relative length (RL ) plotted as a function actual length (Lact) for cis A5
(red triangles), trans A5 (purple circles), cis ATATA (green triangles), and trans
ATATA (blue circles). Error bars and average are from three gels without
compound.
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Figure 3.17 Average relative length (RL) plotted as a function actual length (Lact) for cis A5
(red triangles), trans A5 (green circles), cis ATATA (green triangles), and trans
ATATA (blue circles). Error bars and average are from three gels with DB75.
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Figure 3.18 Average relative length (RL-1) plotted as a function actual length squared
(Lact2) for cis A5 (red triangles), trans A5 (purple circles), cis ATATA (green
triangles), and trans ATATA (blue circles). Error bars and average are from
three gels without compound. Datum for the cis A5 189 bp multimer is missing
because it was indistinguishable from a circular band co-migrating with it.
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Table 3.7 Average and standard deviation of Cr values from multiple gels for four
oligomers in the presence or absence of DB75.
cis A5
No
cmpd
DB75

1.00
0.82

1.03
0.84

0.97
0.82

cis ATATA
No
cmpd
DB75

0.32
0.78

0.33
0.80

0.31
0.76

avg

stdev

1.00
0.83

0.03
0.01

avg

stdev

0.32
0.78

0.01
0.02

trans A5
0.56
0.44

0.59
0.46

0.54
N/A

trans ATATA
0.22
0.35

0.23
0.38

0.25
N/A

avg

stdev

0.56
0.45

0.02
0.01

avg

stdev

0.24
0.36

0.02
0.02

3.5 Effects of compound on markers
The basis for molecular weight assignment is the 20 bp marker. Since the calculation of
relative curvature relies on relative mobility and this in turn relies upon the molecular weight or
number of base pairs of each oligomer, it is very important that the compounds under study
affect only the mobility of the oligomers and not the markers. The presence of two 100 bp
fragments of differing sequence in the commercially available marker may explain why the 100
bp band was sometimes very wide and, in a few cases, split into two bands (Figure 3.19). This
suggests that the compounds affected their mobility, causing them to migrate differently enough
to be resolved from one another. The band splitting was never observed in gels where compound
was absent.
The 20 bp commercial ladder that was used contains an AATT site, and in order to
determine if the 20 bp ladder’s mobility was being changed, two gels, one experiment with
DB75 and one without, were performed simultaneously on either side of a single gel apparatus,
so that the conditions were as similar as possible. Results (not shown) suggested that differences
were not significant, but since some bands appeared to be shifted, further analysis was performed
to determine to what extent Cr values were affected.
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Figure 3.19 8% PAGE (19:1) showing the splitting of the 20 bp commercial marker’s (M1)
100-bp band as indicated by the arrow. Gel contains 0.1 µM DB940. Numbers
on top correspond to oligomers previously listed in Figure 3.1.

While initial experiments seemed to indicate a small to nonexistent change in marker
mobility due to compound in the gel, results such as those in Figure 3.19 (above) suggested that
compounds could induce marker mobility changes and thus it was important to have a marker
present that did not have a compound binding site. Further gel electrophoresis experiments were
performed to explore the effect of compound in gels on markers M1 and M2, and to determine if
compound was even needed in gels to get accurate Cr values.
Results for cis A5 shown in Figure 3.20 suggest that there is a small difference in RL
depending on whether or not molecular weight assignments are made using M1 or M2 even
when there is no compound in the gel. Bands assigned using the mobility of M1 (red markers)
are consistently lower than those assigned by M2 (blue markers) cis A5. However, the direction
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of change caused by DB75 (causing an increase in mobility) is the same regardless of which
marker is used. No difference in RL is seen between 1:1 and 2:1 ratios for cis A5. Figure 3.21
shows similar results to those in Figure 3.20, wherein the values for RL are less when assigned
using M1. Regardless of the marker used, it is apparent that DB75 caused a shift in the mobility
of cis AAATT in the same direction as cis A5. However, in this case, RL does differ depending
on the ratio, with 2:1 having almost the same RL values as cis AAATT with no compound. The
1:1 values are far less. Figure 3.22 shows results for cis ATATA similar to those already
described for the other two sequences except that the direction of mobility change for cis
ATATA in the presence of DB75 was in the opposite direction as the other two. Cis ATATA
also shows a dependence upon ratio, except that in this case, 2:1 had greater RL values than 1:1.
Overall, the direction of change is consistent with results from previous gels when compound
was present in the gel regardless of which marker was used to make the molecular weight
assignment. This was to be expected, since no compound was present in the gels in Figures
3.20-3.22 and markers were not incubated with compound prior to electrophoresis. Results in
Figure 3.21, where RL changes significantly with the change in ratio of DB75 from 1:1 to 2:1 for
cis AAATT, may indicate that some secondary binding is occurring; the direction of mobility
change (slower) is consistent with intercalation as the possible binding mode. However, DB75
has been shown to intercalate at higher concentrations only in GC or mixed sequences.40
Clearly, something unusual is happening to AAATT that does not occur in either of the other
sequences
Overall, these results seem to suggest that compound is not needed in the gel, at least for
A5 and cis ATATA, since the difference in mobility over the range used to find Cr does not differ
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from 1:1 and 2:1. This small difference suggests that binding sites are already occupied and
additional compound is not causing a significant change in topology.
A comparison of Figures 3.24-3.26 (DB75 is present in the gel) with previous figures
(Figures 3.20-3.22, no DB75), shows that for cis A5 and cis ATATA the difference between the
1:1 and 2:1 plots is smaller. This makes sense since the presence of compound in the gel makes
the initial ratio incubated with the DNA prior to electrophoresis less important. When DB75 is
present in the gel the plots of RL vs Lact created based on M2 are still higher, which is consistent
with the results for RL plots when no compound was present. This suggests that if a change is
induced in M1 by compound it is small or nonexistent and probably does not have a large effect
on molecular weight assignment.
In order to determine if the absence of compound in the gel would result in different
values for Cr, RL vs Lact plots for each sequence at a ratio of 2:1 and assigned using M2 (from
Figures 3.20-3.22 and 3.24-3.26) were placed on the same axis to make their comparison easier.
While there is little difference between the plots for cis ATATA, there is a large difference
between them for cis A5 and cis AAATT (Figures 3.27 and 3.28). This difference is well beyond
experimental error, which indicates that for some sequences there will be a significant difference
in Cr depending on whether or not there is compound in the gel.
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Figure 3.20 Plot of RL vs Lact for cis A5 with molecular weight assignment from either the
20 bp commercial ladder (M1), or the shuffled 21 bp marker (M2). Ratios
indicate the concentration of DB75 incubated with the DNA relative to the
concentration of binding sites. No compound was present in the gel (8%, 29:1).

52

2.5
cis AAATT 0 M1
cis AAATT 0 M2
cis AAATT 1:1 M1
cis AAATT 1:1 M2
cis AAATT 2:1 M1
cis AAATT 2:1 M2

2

R

L

1.5

1

0

50

100

150

200

250

L

act

Figure 3.21 Plot of RL-1 vs Lact2 for cis AAATT with molecular weight assignment from
either the 20 bp commercial ladder (M1), or the shuffled 21 bp marker (M2).
Ratios indicate the concentration of DB75 incubated with the DNA relative to
the concentration of binding sites. No compound was present in the gel (8%,
29:1).
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Figure 3.22 Plot of RL-1 vs Lact2 for cis ATATA with molecular weight assignment from
either the 20 bp commercial ladder (M1), or the shuffled 21 bp marker (M2).
Ratios indicate the concentration of DB75 incubated with the DNA relative to
the concentration of binding sites. No compound was present in the gel (8%,
29:1).
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Figure 3.23 PAGE (8%, 29:1) that produced data for Figure 3.19-3.21. No compound was
present in the gel. Ratios indicate the concentration of DB75 incubated with
sample relative to the concentration of binding sites of the sequence shown prior
to electrophoresis.
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Figure 3.24 Plot of RL vs Lact for cis A5 with molecular weight assignment from either the
20 bp commercial ladder (M1), or the shuffled 21 bp marker (M2). Ratios
indicate the concentration of DB75 incubated with the DNA relative to the
concentration of binding sites. DB75 (0.1 µM) was present in the gel (8%, 29:1).
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Figure 3.25 Plot of RL vs Lact for cis AAATT with molecular weight assignment from either
the 20 bp commercial ladder (M1), or the shuffled 21 bp marker (M2). Ratios
indicate the concentration of DB75 incubated with the DNA relative to the
concentration of binding sites. DB75 (0.1 µM) was present in the gel (8%, 29:1).
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Figure 3.26 Plot of RL vs Lact for cis ATATA with molecular weight assignment from either
the 20 bp commercial ladder (M1), or the shuffled 21 bp marker (M2). Ratios
indicate the concentration of DB75 incubated with the DNA relative to the
concentration of binding sites. DB75 (0.1 µM) was present in the gel (8%, 29:1).
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Figure 3.27 PAGE (8%, 29:1) that produced data for Figure 3.24-3.26. DB75 was present in
the gel at 0.1 µM. Ratios indicate the concentration of DB75 incubated with
sample relative to the concentration of binding sites of the sequence shown prior
to electrophoresis.
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Figure 3.28 Plot of RL vs Lact for cis A5 with (purple circles) and without (red triangles)
DB75 in the gel at 2:1 ratio of compound to DNA incubated prior to
electrophoresis and assigned relative to M2.
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Figure 3.29 Plot of RL vs Lact for cis AAATT (top) and cis ATATA (bottom) with (purple
circles) and without (red triangles) DB75 in the gel at 2:1 ratio of compound to
DNA incubated prior to electrophoresis and assigned relative to M2.
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3.6 Cyclization assays
Cyclization assay results mirror those from the ligation ladders, emphasizing the
differential effect diamidines can have on DNA topology depending on the sequence. The figure
below shows the effects of different compounds on circle formation when 1 µM DNA (2 µM
binding sites) is ligated in the presence of 2 µM of ligand (Figure 3.30).

Figure 3.30 PAGE (8%, 29:1) from the cyclization assay performed on cis A5 and cis
ATATA (1 µM DNA, 2 µM binding sites) in the absence and presence (1:1)
three different compounds. Bal-31± indicates whether or not sample was
digested prior to electrophoresis. M indicates 100 bp marker, double intensity
band is 500 bp.
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Differences in the intensity of the bands make it apparent that cyclization efficiency is
compound dependent, especially for cis A5. The band intensities from Figure 3.30 were
transformed into a plot of cyclization efficiency as a function of circle size for cis A5 (Figure
3.31). This plot shows quantitatively the effect of compound on cyclization and Cr can be
calculated from length (L) at maximum cyclization efficiency (E). DB 75 and DB 244 caused a
shift in E from lower molecular weight to higher molecular weight, implying that they
straightened the DNA such that it required an additional duplex in order to efficiently cyclize,
thus a reduction in Cr is expected. Cr from cyclization assays is comparable to those from
ligation ladder assays, except for DB 293 (Table 3.8). This suggests that DB293 deforms DNA
topology in a manner that causes anomalous migration in a gel, giving a large Cr value from
ligation ladder assay, but no change in cyclization efficiency.
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Figure 3.31 Plot of cyclization efficiency (E) as a function of circle size (L) for cis A5 from
the gel in Figure 3.27. Lmax is the value for L where E is at a maximum.
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Table 3.8 Comparison of cis A5 Cr from ligation ladder assays with Cr from cyclization
assays using Equation 4.

No cmpd
DB75
DB244
DB293

Ligation Cyclization
1.00
0.99
0.80
0.80
0.80
0.80
1.19
0.99

In the cis A5 oligomer DB244 and DB 75 inhibit cyclization, with DB244 showing the
greatest change, while DB293 does not seem to differ from the standard. The ligation ladder
experiments affirm the results of cyclization for cis A5; DB75 and DB244 both straighten the
DNA, reducing the Cr values from 1.0 to about 0.8, while DB293 slightly bends the DNA
increasing the Cr value from 1.0 to 1.2. This makes sense, since a reduction in bend would be
expected to produce a reduction in cyclization efficiency, which it clearly does for both DB75
and DB244. Given their similar values for Cr you might expect them to inhibit cyclization to the
same degree, but it is readily apparent that they do not; DB244 is a better inhibitor of cyclization
than DB75. DB293 might also be expected to increase circle formation, due to the increase in Cr
as calculated from ligation ladders. However, it does not appear to do so to any appreciable
extent, which is confirmed by Table 3.8. For the cis ATATA DNA, DB293 enhances circle
formation, presumably via increasing the proximity of the ends through bending, even so far as
to create a band not present in the standard ligation reaction. The other two compounds do not
appear to differ much from the standard assay without ligand. In ligation ladder analysis, all
three compounds significantly changed the mobility of cis ATATA on average from about a Cr
of 0.3 with no compound to 0.7 for DB75 and DB293, with DB244 inducing the greatest bend,
with a Cr of 0.9. Thus, it might be expected that all three compounds would enhance circle
formation, and if any compound created an additional band, it would be DB244. However, only
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DB293 induces a bend great enough for an additional band to be formed at a lower molecular
weight, while the other two ligands do not appear to be much different from the standard.
In order to ensure that changes in cyclization efficiency were due to topological changes
in the DNA and not direct inhibition of the ligase enzyme by the compounds, titrations were
performed for several compounds to see if the abolition of circles was dependent only on ligand
concentration.
Figure 3.32 suggests that topology is the probably reason for changes in cyclization and
not inhibition of ligase. While DB75 inhibited formation of circles in the cis A5 oligomer, which
would be consistent with straightening, the cis ATATA sequence exhibits no inhibition, and
possibly even a slight enhancement of circle formation. These results are consistent with the
previous assay using DB75 shown in Figure 3.27. If ligase inhibition were the probable cause of
differential circle formation, then it is unlikely that different sequences would show different
effects, especially since the overhangs on both oligomers, where ligation occurs, are equivalent.
Instead, both sequences would have shown circle formation inhibited, which is clearly not the
case.
For the cyclization assay using DB293 (Figure 3.33) and distamycin (Figure 3.34),
concentrations of ligand were increased from those used in DB75 to account for the potential
formation of ligand dimers in the binding site. Again, cyclization inhibition is sequence
dependent, with DB293 having an effect on circle formation opposite that of DB75. In this case,
DB293 enhances cis ATATA circle formation, as was seen earlier, and seems to have little effect
on cis A5 circle formation. This emphasizes, yet again, the differential effects similar
compounds can have on the same DNA sequences’ topology.
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Figure 3.32 PAGE (8%, 29:1) from the cyclization assay for DB75 at 0, 1, 2, and 4 µM
incubated with 2 µM DNA.
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Figure 3.33 PAGE (8%, 29:1) from the cyclization assay for DB293 at 0, 1, 2.5, and 5 µM,
incubated with 2 µM DNA.
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Figure 3.34 (8%, 29:1) from the cyclization assay for distamycin at 0, 1, 2.5, and 5 µM,
incubated with 2 µM DNA.

A cyclization assay was performed with distamycin to see if results were consistent with
previously published data indicating that distamycin straightened bent DNA.11 While ligation
ladder results show that is does straighten cisA5, it does so by very little, from 1.00 to about 0.93
and in other sequences it does not straighten at all or straightens an amount smaller than
experimental error. However, for cis A5 and cis ATATA, cyclization assay results show that
circle formation is inhibited in both the A5 and ATATA sequences. This suggests that either
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distamycin does in fact straighten both sequences or it is inhibiting the ligase enzyme and thus
reducing ligation in a non-topologically dependent manner. Unfortunately, the results for
cyclization of cis ATATA and cis A5 with distamycin are not consistent with Cr values from
ligation assays. Cis ATATA and cis A5 Cr values from the ligation assay vary slightly depending
on the ratio of ligand to DNA but show very little change in Cr (typically less than experimental
error). This is not consistent with cyclization assay results which show circle inhibition for both
sequences, albeit only at the higher concentrations. It is not clear whether this indicates that the
Cr value obtained from ligation ladders are not accurate, the ligase enzyme is being inhibited or
whether there is some other mechanism, such as of out-of-plane bending, leading to the apparent
disagreement for some compounds between the ligation ladder results and cyclization assay
results. Perhaps only a small change in bend, such as that induced by distamycin, is enough to
have a noticeable effect on cyclization efficiency.
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Chapter 4: Conclusions
Among the group of heterocyclic diamidines studied here, several induced topological
changes in DNA that were sequence dependent. These changes, while experimentally
significant, are rather small in terms of degrees. Assuming a phased A-tract has a bend of about
18° (estimates range from 17°-22° 27, 41) when Cr = 1.0 then a change in Cr of about 0.2 is the
equivalent of change of about 4°. While this is small, such a change is remarkable for a minor
groove binder, which is usually considered to cause little to no perturbation in DNA topology.
The changes induced by heterocyclic diamidines in AT tracts are even more impressive, with
several compounds able to make this relatively uncurved DNA migrate as if it was as curved as
an A5 tract. In terms of degrees, this is a far more remarkable change of about 11°. It remains to
be seen if these changes are enough to cause disruption of critical biological processes, such as
those in the kDNA of trypanosomes, to an extent that they are deadly to the parasite. The
bending of the ATATA tracts may be due to a narrowing of the groove by the ligand in order to
obtain better groove contacts; perhaps this could disrupt important biological processes.
Unfortunately, no direct correlation was found between compounds that are effective
antiparasitic drugs and those that bend DNA. There also does not appear to be a clear correlation
between topology change and structural motifs. DB75, DB352, and DB1213 differ from one
another only slightly in structure but had large differences in their effect on A5 and ATATA
topology. This may be due to only a limited number of compound motifs being investigated or
may reflect the high sensitivity of the assay.
The two methods investigated here produce results for Cr that typically agree with one
another but are somewhat hard to precisely quantify. The apparent disagreement between the
two assays may indicate that some compounds bind DNA and bend it in an out-of-plane manner.
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Ligation ladder assays are a sensitive tool for probing innate topology in duplexes with a variety
of sequences. However, probing changes in these sequences when DNA binding compounds are
present is somewhat complicated by the disassociation of the DNA-ligand complex even when
using compounds with high binding constants. Placing compound in the PAGE alleviates this
problem, but introduces other issues. With further investigation, it is probable that some of these
complications may be resolved, including the apparent disagreement between ligation assay
results and cyclization results for some compounds. Though they may not be able to provide Cr
values that agree exactly, ligation ladder and cyclization assays have provided evidence that the
compounds investigated here have widely different effects on the topology of sequences that
differ only in their order, and that even analogous compounds (differing only in one atom) may
induce different effects on topology for the same sequence. The lead compound DB75, while
causing a slight straightening of the intrinsically bent A5 sequence, is surprisingly able to bend an
intrinsically straight ATATA sequence.
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